Global Interventional Cardiology and Peripheral Vascular Devices Market Forecast, Trend Analysis And Competition Tracking - Global Market insights 2015 to 2031
-
28753
-
May 2023
-
164
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Interventional Cardiology and Peripheral Vascular Devices Market Introduction:
Global Interventional Cardiology and Peripheral Vascular Devices Market was estimated to be valued at US$ 21,064.32 Mn in 2020 and is projected to revenue at 58,320.39 in 2031 approximately register а САGR of 9.6% by 2031.
Interventional cardiology is a branch of cardiology based on endovascular catheter technologies for the treatment of structural heart diseases. The healthcare industry includes equipment like cardiovascular surgery equipment, cardiac rhythm management (CRM) equipment, interventional cardiology equipment, peripheral vascular equipment, electrophysiological equipment, and others used in cardiovascular surgery to treat arrhythmia other cardiovascular diseases. Peripheral vascular disease (PVD) narrows arteries outside the brain and heart. High blood pressure, diabetes, obesity, and smoking are some of the risk factors associated with PVD growth. Peripheral vascular devices are used to treat blocked arteries and remove accumulated plaque.
A Peripheral Vascular Device is a medical device that is used to treat peripheral vascular disorders. It is inserted into a peripheral artery and can be used to treat symptoms from atherosclerotic plaques, which are deposits of cholesterol and other substances in the arterial wall. Peripheral vascular devices (PVDs) are catheters that are inserted into veins, providing routes for delivering fluids and medications, collecting blood samples or accessing other organs for surgery; these devices can also be used to measure hemoglobin levels and perform electrocardiograms. The peripheral vascular devices used for treatment include Inferior Vena Cava (IVC) filters, Endovascular Aneurysm Repair (EVAR) stent-grafts, angiography catheters, hemodynamic flow changes, and plague modification devices. The main advantages of interventional cardiology or radiology devices are used to reduce scars and pain and recover fast after surgery for a long period.
The increasing prevalence of chronic heart diseases is expected to increase the revenue growth of cardiological devices
The increasing prevalence of chronic heart diseases such as hypertrophic cardiomyopathy, coronary artery, and cardiac failure has increased heart patients' number worldwide. Increasing consumption of junk food, poor lifestyle, smoking, and drinking increases chronic heart disease risk. These factors are driving revenue growth for the interventional cardiology peripheral vascular devices market.
- According to the World Health Organization (WHO), 4 out of 5 cardiovascular diseases (CVD) deaths are due to heart attacks and strokes. One-third of these deaths occur prematurely in people below 70 years of age. Moreover, ~1.9 Mn people die from tobacco-induced heart disease every year.
COVID-19 Impact on the Global Interventional Cardiology and Peripheral Vascular Devices Market
The outbreak of COVID-19 has a negative impact on almost every industry. The medical industry also witnessed strong disruptions in the global supply chain of raw materials, transportation of end-products, delayed clinical trials, and disrupted processes worldwide. This had led to price fluctuations and sudden shortages of raw materials and end-products used in medical procedures.
Trends in Global Interventional Cardiology and Peripheral Vascular Devices Market
Growing awareness in patients regarding coronary heart diseases and peripheral vascular disorders plays a vital role for the market's growth. Several educational, government, non-governmental organizations and key players have launched awareness programs to increase awareness regarding the treatment of these diseases among patients, doctors, and healthcare providers. This factor is expected to impact market growth positively.
Interventional Cardiology and Peripheral Vascular Devices Market Dynamics
The global interventional cardiology and peripheral vascular devices market is segmented into product type, end-use, and regions. The product type segment includes angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, flow alteration devices, and accessories. The angioplasty stents segment accounts for the highest revenue share among the product type segments, owing to its increased adoption and wide use in several heart surgeries. Among the end-use segments, the hospitals account for a significant share in terms of revenue. This is due to the increase in the number of heart operations cases across the globe.
Competitive Landscape
The Global Interventional Cardiology and Peripheral Vascular Devices market landscape appears highly consolidated, with a major chunk of it being dominated by below players.
- Abbott Laboratories
- Braun Melsungen AG
- Boston Scientific Corporation
- R. Bard, Inc.
- Cardinal Health, Inc.
- Cook Medical, Inc.
- Medtronic plc
- Jude Medical, Inc.
- Terumo Corporation
- The Spectranetics Corporation
- Other Key Industry Players
Report Scope
- Forecast Period: 2022-2031
- Actual Year: 2021
- Historical Data Available for: 2015-2020
Global Interventional Cardiology and Peripheral Vascular Devices Market Segmentation Based on Product Type, End-Use, and Region
The Global Interventional Cardiology and Peripheral Vascular Devices Market, By Product Type
- Angioplasty Balloons
- Normal Balloons
- Cutting and Scoring Balloons
- Drug-eluting Balloons
- Angioplasty Stents
- Coronary Stent
- Peripheral Stents
- Angioplasty Catheters
- Angiography Catheters
- Guiding Catheters
- Others
- Endovascular Aneurysm Repair Stent Grafts
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Thrombectomy Devices
- Atherectomy Devices
- Others
- Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
- Accessories
- Vascular Closure Devices
- Guidewires
- Others
The Global Interventional Cardiology and Peripheral Vascular Devices Market, By End-Use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Other End-Uses
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- Abbott Laboratories
- Braun Melsungen AG
- Boston Scientific Corporation
- R. Bard, Inc.
- Cardinal Health, Inc.
- Cook Medical, Inc.
- Medtronic plc
- Jude Medical, Inc.
- Terumo Corporation
- The Spectranetics Corporation
- Other Key Industry Players
Frequently Asked Questions (FAQ)
The major cardiovascular medical devices includes artificial heart valves, endovascular grafts, coronary stents and angioplasty balloon catheters, among others.
1. Amputation (loss of a limb) 2. Poor wound healing. 3. Restricted mobility due to pain or discomfort. 4. Severe pain in the affected extremity.
Recent advancements in peripheral vascular devices have revolutionized the way vascular surgery is practiced. These advances include new mesh that can be used instead of sutures, as well as new devices that cut the time it takes to perform a bypass surgery. These technologies are proving successful and are expanding the possibilities for surgeons to treat patients with vascular disease.
The latest advances in medical devices for interventional cardiology are designed to treat intracardiac problems and potentially save lives. Unlike other cardiovascular systems, the heart is a closed system and any disruption of its rhythm or pumping function can lead to cardiac arrest and death. Doctors can now use these cutting-edge devices to re-establish a steady heartbeat, relieve pressure on the heart and improve circulation.
Our Clients
View Our Licence Options
